392 related articles for article (PubMed ID: 21265735)
1. Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape.
Bartz R; Fan H; Zhang J; Innocent N; Cherrin C; Beck SC; Pei Y; Momose A; Jadhav V; Tellers DM; Meng F; Crocker LS; Sepp-Lorenzino L; Barnett SF
Biochem J; 2011 Apr; 435(2):475-87. PubMed ID: 21265735
[TBL] [Abstract][Full Text] [Related]
2. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
Wang XL; Xu R; Lu ZR
J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
[TBL] [Abstract][Full Text] [Related]
3. Breaking down the barriers: siRNA delivery and endosome escape.
Dominska M; Dykxhoorn DM
J Cell Sci; 2010 Apr; 123(Pt 8):1183-9. PubMed ID: 20356929
[TBL] [Abstract][Full Text] [Related]
4. Endosomal escape pathways for delivery of biologicals.
Varkouhi AK; Scholte M; Storm G; Haisma HJ
J Control Release; 2011 May; 151(3):220-8. PubMed ID: 21078351
[TBL] [Abstract][Full Text] [Related]
5. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C
Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295
[TBL] [Abstract][Full Text] [Related]
6. Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system.
Xiang B; Jia XL; Qi JL; Yang LP; Sun WH; Yan X; Yang SK; Cao DY; Du Q; Qi XR
Int J Nanomedicine; 2017; 12():2385-2405. PubMed ID: 28405163
[TBL] [Abstract][Full Text] [Related]
7. Barriers to successful delivery of short interfering RNA after systemic administration.
White PJ
Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1371-6. PubMed ID: 18565190
[TBL] [Abstract][Full Text] [Related]
8. Fusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenes.
Oliveira S; van Rooy I; Kranenburg O; Storm G; Schiffelers RM
Int J Pharm; 2007 Mar; 331(2):211-4. PubMed ID: 17187949
[TBL] [Abstract][Full Text] [Related]
9. Endosome-disruptive peptides for improving cytosolic delivery of bioactive macromolecules.
Nakase I; Kobayashi S; Futaki S
Biopolymers; 2010; 94(6):763-70. PubMed ID: 20564044
[TBL] [Abstract][Full Text] [Related]
10. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
Akhtar S; Benter I
Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
[TBL] [Abstract][Full Text] [Related]
11. Polycation gene delivery systems: escape from endosomes to cytosol.
Cho YW; Kim JD; Park K
J Pharm Pharmacol; 2003 Jun; 55(6):721-34. PubMed ID: 12841931
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical characterization techniques for lipid based delivery systems for siRNA.
Kapoor M; Burgess DJ; Patil SD
Int J Pharm; 2012 May; 427(1):35-57. PubMed ID: 21979250
[TBL] [Abstract][Full Text] [Related]
13. Endosomal escape and the knockdown efficiency of liposomal-siRNA by the fusogenic peptide shGALA.
Sakurai Y; Hatakeyama H; Sato Y; Akita H; Takayama K; Kobayashi S; Futaki S; Harashima H
Biomaterials; 2011 Aug; 32(24):5733-42. PubMed ID: 21605898
[TBL] [Abstract][Full Text] [Related]
14. Delivery of short interfering RNA using endosomolytic cell-penetrating peptides.
Lundberg P; El-Andaloussi S; Sütlü T; Johansson H; Langel U
FASEB J; 2007 Sep; 21(11):2664-71. PubMed ID: 17463227
[TBL] [Abstract][Full Text] [Related]
15. Application of an HIV gp41-derived peptide for enhanced intracellular trafficking of synthetic gene and siRNA delivery vehicles.
Kwon EJ; Bergen JM; Pun SH
Bioconjug Chem; 2008 Apr; 19(4):920-7. PubMed ID: 18376855
[TBL] [Abstract][Full Text] [Related]
16. Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape.
Endoh T; Ohtsuki T
Adv Drug Deliv Rev; 2009 Jul; 61(9):704-9. PubMed ID: 19383521
[TBL] [Abstract][Full Text] [Related]
17. Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA.
Li Y; Cheng Q; Jiang Q; Huang Y; Liu H; Zhao Y; Cao W; Ma G; Dai F; Liang X; Liang Z; Zhang X
J Control Release; 2014 Feb; 176():104-14. PubMed ID: 24365128
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation.
Akita H; Kogure K; Moriguchi R; Nakamura Y; Higashi T; Nakamura T; Serada S; Fujimoto M; Naka T; Futaki S; Harashima H
J Control Release; 2010 May; 143(3):311-7. PubMed ID: 20080139
[TBL] [Abstract][Full Text] [Related]
19. A non-covalent peptide-based strategy for siRNA delivery.
Crombez L; Charnet A; Morris MC; Aldrian-Herrada G; Heitz F; Divita G
Biochem Soc Trans; 2007 Feb; 35(Pt 1):44-6. PubMed ID: 17233597
[TBL] [Abstract][Full Text] [Related]
20. Novel polymerizable surfactants with pH-sensitive amphiphilicity and cell membrane disruption for efficient siRNA delivery.
Wang XL; Ramusovic S; Nguyen T; Lu ZR
Bioconjug Chem; 2007; 18(6):2169-77. PubMed ID: 17939730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
